CAD 0.19
(-2.7%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 132.46 Thousand CAD | -8.68% |
2022 | 145.05 Thousand CAD | -38.7% |
2021 | 236.62 Thousand CAD | -29.03% |
2020 | 333.39 Thousand CAD | 58.46% |
2019 | 210.39 Thousand CAD | 51.51% |
2018 | 138.86 Thousand CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
2014 | - CAD | 0.0% |
2013 | - CAD | 0.0% |
2012 | - CAD | 0.0% |
2011 | - CAD | 0.0% |
2010 | - CAD | 0.0% |
2009 | - CAD | 0.0% |
2008 | - CAD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 188.93 Thousand CAD | 24.13% |
2024 Q1 | 152.2 Thousand CAD | 14.9% |
2023 Q4 | 132.46 Thousand CAD | -1.37% |
2023 Q3 | 134.3 Thousand CAD | -1.28% |
2023 Q2 | 136.04 Thousand CAD | -24.36% |
2023 Q1 | 179.85 Thousand CAD | 23.99% |
2023 FY | 132.46 Thousand CAD | -8.68% |
2022 Q3 | 252.24 Thousand CAD | -8.7% |
2022 Q4 | 145.05 Thousand CAD | -42.5% |
2022 FY | 145.05 Thousand CAD | -38.7% |
2022 Q1 | 289.29 Thousand CAD | 22.26% |
2022 Q2 | 276.3 Thousand CAD | -4.49% |
2021 Q1 | 375.95 Thousand CAD | 12.77% |
2021 Q2 | 429.03 Thousand CAD | 14.12% |
2021 Q3 | 392.11 Thousand CAD | -8.6% |
2021 Q4 | 236.62 Thousand CAD | -39.65% |
2021 FY | 236.62 Thousand CAD | -29.03% |
2020 Q2 | 439.42 Thousand CAD | 111.23% |
2020 Q3 | 506.41 Thousand CAD | 15.24% |
2020 Q4 | 333.39 Thousand CAD | -34.16% |
2020 FY | 333.39 Thousand CAD | 58.46% |
2020 Q1 | 208.03 Thousand CAD | -1.12% |
2019 Q4 | 210.39 Thousand CAD | -4.7% |
2019 FY | 210.39 Thousand CAD | 51.51% |
2019 Q1 | 133.36 Thousand CAD | -3.96% |
2019 Q3 | 220.78 Thousand CAD | 72.79% |
2019 Q2 | 127.77 Thousand CAD | -4.19% |
2018 Q1 | - CAD | 0.0% |
2018 FY | 138.86 Thousand CAD | 0.0% |
2018 Q4 | 138.86 Thousand CAD | 68.82% |
2018 Q3 | 82.25 Thousand CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2015 Q2 | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
2015 Q4 | - CAD | 0.0% |
2015 Q1 | - CAD | 0.0% |
2014 Q3 | - CAD | 0.0% |
2014 Q1 | - CAD | 0.0% |
2014 FY | - CAD | 0.0% |
2014 Q4 | - CAD | 0.0% |
2014 Q2 | - CAD | 0.0% |
2013 Q2 | - CAD | 0.0% |
2013 Q1 | - CAD | 0.0% |
2013 FY | - CAD | 0.0% |
2013 Q4 | - CAD | 0.0% |
2013 Q3 | - CAD | 0.0% |
2012 Q4 | - CAD | 0.0% |
2012 Q1 | - CAD | 0.0% |
2012 Q2 | - CAD | 0.0% |
2012 Q3 | - CAD | 0.0% |
2012 FY | - CAD | 0.0% |
2011 Q1 | - CAD | 0.0% |
2011 Q3 | - CAD | 0.0% |
2011 Q4 | - CAD | 0.0% |
2011 FY | - CAD | 0.0% |
2011 Q2 | - CAD | 0.0% |
2010 Q3 | - CAD | 0.0% |
2010 FY | - CAD | 0.0% |
2010 Q2 | - CAD | 0.0% |
2010 Q1 | - CAD | 0.0% |
2010 Q4 | - CAD | 0.0% |
2009 Q3 | - CAD | 0.0% |
2009 Q4 | - CAD | 0.0% |
2009 FY | - CAD | 0.0% |
2009 Q2 | - CAD | 0.0% |
2008 FY | - CAD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | - CAD | -Infinity% |
Asep Medical Holdings Inc | - CAD | -Infinity% |
BetterLife Pharma Inc. | - CAD | -Infinity% |
BioVaxys Technology Corp. | - CAD | -Infinity% |
ChitogenX Inc. | - CAD | -Infinity% |
Defence Therapeutics Inc. | -35.44 Thousand CAD | 473.77% |
Entheon Biomedical Corp. | -6233.00 CAD | 2225.269% |
Gemina Laboratories Ltd. | - CAD | -Infinity% |
Glow Lifetech Corp. | 120.53 Thousand CAD | -9.899% |
Lexston Life Sciences Corp. | 46.03 Thousand CAD | -187.774% |
Pharmala Biotech Holdings Inc. | 122.19 Thousand CAD | -8.41% |
Doseology Sciences Inc. | 39.7 Thousand CAD | -233.631% |
MYND Life Sciences Inc. | - CAD | -Infinity% |
Nova Mentis Life Science Corp. | -6970.00 CAD | 2000.545% |
PharmaTher Holdings Ltd. | -8330.00 CAD | 1690.252% |
PreveCeutical Medical Inc. | - CAD | -Infinity% |
Telescope Innovations Corp. | - CAD | -Infinity% |